These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34980538)

  • 1. Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes.
    Coratti G; Carmela Pera M; Montes J; Scoto M; Pasternak A; Bovis F; Sframeli M; D'Amico A; Pane M; Albamonte E; Antonaci L; Lia Frongia A; Mizzoni I; Sansone VA; Russo M; Bruno C; Baranello G; Messina S; Dunaway Young S; Glanzman AM; Duong T; de Sanctis R; Stacy Mazzone E; Milev E; Rohwer A; Civitello M; Darras BT; Bertini E; Day J; Muntoni F; De Vivo DC; Finkel RS; Mercuri E
    Neuromuscul Disord; 2022 Jan; 32(1):36-42. PubMed ID: 34980538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised upper limb module for spinal muscular atrophy: 12 month changes.
    Pera MC; Coratti G; Mazzone ES; Montes J; Scoto M; De Sanctis R; Main M; Mayhew A; Muni Lofra R; Dunaway Young S; Glanzman AM; Duong T; Pasternak A; Ramsey D; Darras B; Day JW; Finkel RS; De Vivo DC; Sormani MP; Bovis F; Straub V; Muntoni F; Pane M; Mercuri E;
    Muscle Nerve; 2019 Apr; 59(4):426-430. PubMed ID: 30677148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper limb module in non-ambulant patients with spinal muscular atrophy: 12 month changes.
    Sivo S; Mazzone E; Antonaci L; De Sanctis R; Fanelli L; Palermo C; Montes J; Pane M; Mercuri E
    Neuromuscul Disord; 2015 Mar; 25(3):212-5. PubMed ID: 25500010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study.
    Pechmann A; Behrens M; Dörnbrack K; Tassoni A; Wenzel F; Stein S; Vogt S; Zöller D; Bernert G; Hagenacker T; Schara-Schmidt U; Walter MC; Bertsche A; Vill K; Baumann M; Baumgartner M; Cordts I; Eisenkölbl A; Flotats-Bastardas M; Friese J; Günther R; Hahn A; Horber V; Husain RA; Illsinger S; Jahnel J; Johannsen J; Köhler C; Kölbel H; Müller M; von Moers A; Schwerin-Nagel A; Reihle C; Schlachter K; Schreiber G; Schwartz O; Smitka M; Steiner E; Trollmann R; Weiler M; Weiß C; Wiegand G; Wilichowski E; Ziegler A; Lochmüller H; Kirschner J;
    Orphanet J Rare Dis; 2022 Oct; 17(1):384. PubMed ID: 36274155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3.
    Wolfe A; Stimpson G; Ramsey D; Coratti G; Dunaway Young S; Mayhew A; Pane M; Rohwer A; Muni Lofra R; Duong T; O'Reilly E; Milev E; Civitello M; Sansone VA; D'Amico A; Bertini E; Messina S; Bruno C; Albamonte E; Mazzone E; Main M; Montes J; Glanzman AM; Zolkipli-Cunningham Z; Pasternak A; Marini-Bettolo C; Day JW; Darras BT; De Vivo DC; Baranello G; Scoto M; Finkel RS; Mercuri E; Muntoni F;
    J Neuromuscul Dis; 2024; 11(3):665-677. PubMed ID: 38427497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal changes in respiratory and upper limb function in a pediatric type III spinal muscular atrophy cohort after loss of ambulation.
    Wolfe A; Scoto M; Milev E; Muni Lofra R; Abbott L; Wake R; Rohwer A; Main M; Baranello G; Mayhew A; Marini-Bettolo C; Muntoni F
    Muscle Nerve; 2021 Nov; 64(5):545-551. PubMed ID: 34432301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: an observational multicenter trial.
    Seferian AM; Moraux A; Canal A; Decostre V; Diebate O; Le Moing AG; Gidaro T; Deconinck N; Van Parys F; Vereecke W; Wittevrongel S; Annoussamy M; Mayer M; Maincent K; Cuisset JM; Tiffreau V; Denis S; Jousten V; Quijano-Roy S; Voit T; Hogrel JY; Servais L
    PLoS One; 2015; 10(4):e0121799. PubMed ID: 25861036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the upper limb function, strength, and mobility in treatment-naive children with spinal muscular atrophy Types 2 and 3.
    Milev E; Selby V; Wolfe A; Rohwer A; Tillmann R; Ramsey D; Iodice M; Hogrel JY; Baranello G; Scoto M; Muntoni F
    Muscle Nerve; 2024 Mar; 69(3):340-348. PubMed ID: 38238963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen.
    Coratti G; Pane M; Lucibello S; Pera MC; Pasternak A; Montes J; Sansone VA; Duong T; Dunaway Young S; Messina S; D'Amico A; Civitello M; Glanzman AM; Bruno C; Salmin F; Tacchetti P; Carnicella S; Sframeli M; Antonaci L; Frongia AL; De Vivo DC; Darras BT; Day J; Bertini E; Muntoni F; Finkel R; Mercuri E;
    Neuromuscul Disord; 2021 Jul; 31(7):596-602. PubMed ID: 34099377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 - A Prospective Observational Study.
    Walter MC; Wenninger S; Thiele S; Stauber J; Hiebeler M; Greckl E; Stahl K; Pechmann A; Lochmüller H; Kirschner J; Schoser B
    J Neuromuscul Dis; 2019; 6(4):453-465. PubMed ID: 31594243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revised upper limb module for spinal muscular atrophy: Development of a new module.
    Mazzone ES; Mayhew A; Montes J; Ramsey D; Fanelli L; Young SD; Salazar R; De Sanctis R; Pasternak A; Glanzman A; Coratti G; Civitello M; Forcina N; Gee R; Duong T; Pane M; Scoto M; Pera MC; Messina S; Tennekoon G; Day JW; Darras BT; De Vivo DC; Finkel R; Muntoni F; Mercuri E
    Muscle Nerve; 2017 Jun; 55(6):869-874. PubMed ID: 27701745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different trajectories in upper limb and gross motor function in spinal muscular atrophy.
    Coratti G; Pera MC; Montes J; Pasternak A; Scoto M; Baranello G; Messina S; Dunaway Young S; Glanzman AM; Duong T; De Sanctis R; Mazzone ES; Milev E; Rohwer A; Civitello M; Pane M; Antonaci L; Frongia AL; Sframeli M; Vita GL; DʼAmico A; Mizzoni I; Albamonte E; Darras BT; Bertini E; Sansone VA; Bovis F; Day J; Bruno C; Muntoni F; De Vivo DC; Finkel R; Mercuri E
    Muscle Nerve; 2021 Nov; 64(5):552-559. PubMed ID: 34327716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study.
    Annoussamy M; Seferian AM; Daron A; Péréon Y; Cances C; Vuillerot C; De Waele L; Laugel V; Schara U; Gidaro T; Lilien C; Hogrel JY; Carlier P; Fournier E; Lowes L; Gorni K; Ly-Le Moal M; Hellbach N; Seabrook T; Czech C; Hermosilla R; Servais L;
    Ann Clin Transl Neurol; 2021 Feb; 8(2):359-373. PubMed ID: 33369268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international study.
    Coratti G; Bovis F; Pera MC; Scoto M; Montes J; Pasternak A; Mayhew A; Muni-Lofra R; Duong T; Rohwer A; Dunaway Young S; Civitello M; Salmin F; Mizzoni I; Morando S; Pane M; Albamonte E; D'Amico A; Brolatti N; Sframeli M; Marini-Bettolo C; Sansone VA; Bruno C; Messina S; Bertini E; Baranello G; Day J; Darras BT; De Vivo DC; Hirano M; Muntoni F; Finkel R; Mercuri E;
    Eur J Neurol; 2024 Aug; 31(8):e16309. PubMed ID: 38656662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age and baseline values predict 12 and 24-month functional changes in type 2 SMA.
    Coratti G; Pera MC; Lucibello S; Montes J; Pasternak A; Mayhew A; Glanzman AM; Young SD; Pane M; Scoto M; Messina S; Goemans N; Osorio AN; Pedemonte M; Sansone V; Bertini E; De Vivo DC; Finkel R; Muntoni F; Mercuri E;
    Neuromuscul Disord; 2020 Sep; 30(9):756-764. PubMed ID: 32900576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nusinersen in pediatric and adult patients with type III spinal muscular atrophy.
    Pera MC; Coratti G; Bovis F; Pane M; Pasternak A; Montes J; Sansone VA; Dunaway Young S; Duong T; Messina S; Mizzoni I; D'Amico A; Civitello M; Glanzman AM; Bruno C; Salmin F; Morando S; De Sanctis R; Sframeli M; Antonaci L; Frongia AL; Rohwer A; Scoto M; De Vivo DC; Darras BT; Day J; Martens W; Patanella KA; Bertini E; Muntoni F; Finkel R; Mercuri E;
    Ann Clin Transl Neurol; 2021 Aug; 8(8):1622-1634. PubMed ID: 34165911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gain and loss of abilities in type II SMA: A 12-month natural history study.
    Coratti G; Lucibello S; Pera MC; Duong T; Muni Lofra R; Civitello M; D'Amico A; Goemans N; Darras BT; Bruno C; Sansone VA; Day J; Nascimento Osorio A; Muntoni F; Montes J; Sframeli M; Finkel R; Mercuri E;
    Neuromuscul Disord; 2020 Sep; 30(9):765-771. PubMed ID: 32893082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing upper limb function in nonambulant SMA patients: development of a new module.
    Mazzone E; Bianco F; Martinelli D; Glanzman AM; Messina S; De Sanctis R; Main M; Eagle M; Florence J; Krosschell K; Vasco G; Pelliccioni M; Lombardo M; Pane M; Finkel R; Muntoni F; Bertini E; Mercuri E
    Neuromuscul Disord; 2011 Jun; 21(6):406-12. PubMed ID: 21421316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risdiplam in non-sitter patients aged 16 years and older with 5q spinal muscular atrophy.
    Ñungo Garzón NC; Pitarch Castellano I; Sevilla T; Vázquez-Costa JF
    Muscle Nerve; 2023 May; 67(5):407-411. PubMed ID: 36815750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot study.
    Kirschner J; Schorling D; Hauschke D; Rensing-Zimmermann C; Wein U; Grieben U; Schottmann G; Schara U; Konrad K; Müller-Felber W; Thiele S; Wilichowski E; Hobbiebrunken E; Stettner GM; Korinthenberg R
    Neuromuscul Disord; 2014 Feb; 24(2):134-42. PubMed ID: 24300782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.